These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37595667)

  • 1. A photo-activable nano-agonist for the two-signal model of T cell in vivo activation.
    You Y; Jin F; Du Y; Zhu L; Liu D; Zhu M; Du Y; Lang J; Li W; Ji JS; Du YZ
    J Control Release; 2023 Sep; 361():681-693. PubMed ID: 37595667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanoscale artificial antigen presenting cells for cancer immunotherapy.
    Rhodes KR; Green JJ
    Mol Immunol; 2018 Jun; 98():13-18. PubMed ID: 29525074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NSOM/QD-based direct visualization of CD3-induced and CD28-enhanced nanospatial coclustering of TCR and coreceptor in nanodomains in T cell activation.
    Zhong L; Zeng G; Lu X; Wang RC; Gong G; Yan L; Huang D; Chen ZW
    PLoS One; 2009 Jun; 4(6):e5945. PubMed ID: 19536289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor-Microenvironment-Activatable Polymer Nano-Immunomodulator for Precision Cancer Photoimmunotherapy.
    Liu J; He S; Luo Y; Zhang Y; Du X; Xu C; Pu K; Wang J
    Adv Mater; 2022 Feb; 34(8):e2106654. PubMed ID: 34854147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 808 nm-activable core@multishell upconverting nanoparticles with enhanced stability for efficient photodynamic therapy.
    Martínez R; Polo E; Barbosa S; Taboada P; Del Pino P; Pelaz B
    J Nanobiotechnology; 2020 Jun; 18(1):85. PubMed ID: 32503549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Self-delivery of metal-coordinated NIR-II nanoadjuvants for multimodal imaging-guided photothermal-chemodynamic amplified immunotherapy.
    Dai Y; Li X; Xue Y; Chen K; Jiao G; Zhu L; Li M; Fan Q; Dai Y; Zhao Q; Shen Q
    Acta Biomater; 2023 Aug; 166():496-511. PubMed ID: 37230439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intratumoral immunotherapy using a TLR2/3 agonist, L-pampo, induces robust antitumor immune responses and enhances immune checkpoint blockade.
    Lee WS; Kim DS; Kim JH; Heo Y; Yang H; Go EJ; Kim JH; Lee SJ; Ahn BC; Yum JS; Chon HJ; Kim C
    J Immunother Cancer; 2022 Jun; 10(6):. PubMed ID: 35764365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
    Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
    Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnetic field-induced T cell receptor clustering by nanoparticles enhances T cell activation and stimulates antitumor activity.
    Perica K; Tu A; Richter A; Bieler JG; Edidin M; Schneck JP
    ACS Nano; 2014 Mar; 8(3):2252-60. PubMed ID: 24564881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual-Pronged Attack: pH-Driven Membrane-Anchored NIR Dual-Type Nano-Photosensitizer Excites Immunogenic Pyroptosis and Sequester Immune Checkpoint for Enhanced Prostate Cancer Photo-Immunotherapy.
    Wang H; He Z; Gao Y; Feng D; Wei X; Huang Y; Hou J; Li S; Zhang W
    Adv Sci (Weinh); 2023 Oct; 10(28):e2302422. PubMed ID: 37544896
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy.
    Zhao P; Wang M; Chen M; Chen Z; Peng X; Zhou F; Song J; Qu J
    Biomaterials; 2020 Sep; 254():120142. PubMed ID: 32485591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor microenvironment remodeling and tumor therapy based on M2-like tumor associated macrophage-targeting nano-complexes.
    Han S; Wang W; Wang S; Yang T; Zhang G; Wang D; Ju R; Lu Y; Wang H; Wang L
    Theranostics; 2021; 11(6):2892-2916. PubMed ID: 33456579
    [No Abstract]   [Full Text] [Related]  

  • 13. Intratumoral immunotherapy with TLR7/8 agonist MEDI9197 modulates the tumor microenvironment leading to enhanced activity when combined with other immunotherapies.
    Mullins SR; Vasilakos JP; Deschler K; Grigsby I; Gillis P; John J; Elder MJ; Swales J; Timosenko E; Cooper Z; Dovedi SJ; Leishman AJ; Luheshi N; Elvecrog J; Tilahun A; Goodwin R; Herbst R; Tomai MA; Wilkinson RW
    J Immunother Cancer; 2019 Sep; 7(1):244. PubMed ID: 31511088
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nano-Immune-Engineering Approaches to Advance Cancer Immunotherapy: Lessons from Ultra-pH-Sensitive Nanoparticles.
    Li S; Bennett ZT; Sumer BD; Gao J
    Acc Chem Res; 2020 Nov; 53(11):2546-2557. PubMed ID: 33063517
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Photothermal immunotherapy of melanoma using TLR-7 agonist laden tobacco mosaic virus with polydopamine coat.
    Nkanga CI; Ortega-Rivera OA; Steinmetz NF
    Nanomedicine; 2022 Aug; 44():102573. PubMed ID: 35728739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A TIGIT-based chimeric co-stimulatory switch receptor improves T-cell anti-tumor function.
    Hoogi S; Eisenberg V; Mayer S; Shamul A; Barliya T; Cohen CJ
    J Immunother Cancer; 2019 Sep; 7(1):243. PubMed ID: 31500665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dual pH-responsive charge-reversal and photo-crosslinkable polymer nanoparticles for controlled drug release.
    Wang M; He K; Li J; Shen T; Li Y; Xu Y; Yuan C; Dai L
    J Biomater Sci Polym Ed; 2020 May; 31(7):849-868. PubMed ID: 32009554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Leukocyte function-associated antigen 1 is an activation molecule for human T cells.
    Wacholtz MC; Patel SS; Lipsky PE
    J Exp Med; 1989 Aug; 170(2):431-48. PubMed ID: 2569026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Near-Infrared Nano-Optogenetic Activation of Cancer Immunotherapy via Engineered Bacteria.
    Zhu X; Chen S; Hu X; Zhao L; Wang Y; Huang J; Chen J; Qiu Y; Zhang X; Wang M; Yang X; Zhang Y; Zhu Y
    Adv Mater; 2023 Feb; 35(8):e2207198. PubMed ID: 36314411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Semiconducting polymer nano-PROTACs for activatable photo-immunometabolic cancer therapy.
    Zhang C; Zeng Z; Cui D; He S; Jiang Y; Li J; Huang J; Pu K
    Nat Commun; 2021 May; 12(1):2934. PubMed ID: 34006860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.